On Friday, FDA sent him a letter notifying him of his violations
The doctor who created a genetically modified “three-parent baby” has been reprimanded by the Food and Drug Administration for aggressively marketing the unapproved experimental procedure.
John Zhang, CEO of the New Hope Fertility Center in New York, famously combined the DNA of three people to help a mother who was a carrier for a genetic disease conceive an apparently healthy baby boy last year. Now, Zhang and his company are marketing the pricy procedure as the “first proven treatment for certain genetic disorders and a successful solution to age-related infertility.”
However, the FDA does not allow clinical research in people that would involve genetically modifying an embryo. And because Zhang’s technique and the one child it produced are both still in their infancy, we don’t know how well the treatment really works, or if it comes with any unforeseen consequences. On Friday, the FDA posted a letter to Zhang online, informing him that marketing the procedure is illegal, since the FDA hasn’t given him permission to...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Aggregated News
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...
The U.S. government must move “quickly and decisively” to avert substantial national security risks stemming from artificial intelligence (AI) which could, in the worst case, cause an “extinction-level threat to the human species,” says a report commissioned by the U.S...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.